Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OncoTherapy Science Inc.
DescriptionChimeric humanized mAb against FZD10
Molecular Target Frizzled homolog 10 (FZD10)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSarcoma
Indication DetailsTreat synovial sarcoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today